SPONSOR
Jianbin Bi
Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Metastatic Castration-resistant Prostate Cancer
Jianbin Bi is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Metastatic Castration-resistant Prostate Cancer.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Jianbin Bi
How many clinical trials has Jianbin Bi sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Jianbin Bi, of which 1 are actively recruiting participants. These trials cover conditions including Metastatic Castration-resistant Prostate Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Jianbin Bi research focus on?
Jianbin Bi clinical trials span Metastatic Castration-resistant Prostate Cancer. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Jianbin Bi clinical trial?
To participate in a Jianbin Bi trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Jianbin Bi trials with current recruitment status updated daily.
Clinical Trials by Jianbin Bi
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology